Authors: FERRIERE JP ASSIER I CURE H CHARRIER S KWIATKOWSKI F ACHARD JL DAUPLAT J CHOLLET P

Citation: Jp. Ferriere et al., PRIMARY CHEMOTHERAPY IN BREAST-CANCER - CORRELATION BETWEEN TUMOR RESPONSE AND PATIENT OUTCOME, American journal of clinical oncology, 21(2), 1998, pp. 117-120

Authors: CHARRIER S FERRIERE JP KWIATKOWSKI F CURE H VANPRAAGH I FEILLEL V ASSIER I BAY JO DAUPLAT J CHOLLET P

Citation: S. Charrier et al., OPTIMAL DURATION OF NEOADJUVANT CHEMOTHERAPY - 3 OR 4 VERSUS 6 CYCLESIN 3 SCHEMES FOR OPERABLE BREAST-CANCER, European journal of cancer, 33, 1997, pp. 360-360

Authors: CURE H CHARRIER S FERRIERE JP VANPRAAGH I ASSIER I FEILLEL V DELATOUR M BAY JO ACHARD JL DAUPLAT J CHOLLET P

Citation: H. Cure et al., RESULTS OF 3 NEOADJUVANT CHEMOTHERAPY REG IMEN FOR OPERABLE BREAST-CANCER, Bulletin du cancer, 84(1), 1997, pp. 31-34

Authors: VANPRAGGH I FERRIERE JP CURE H FEILLEL V LEBOUEDEC G DELATOUR M ROLHION C CHARRIER S ASSIER I MISSET JL DAUPLAT J CHOLLET P

Citation: I. Vanpraggh et al., COMPARISON OF 3 NEOADJUVANT CHEMOTHERAPY REGIMENS FOR OPERABLE BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 53-53

Authors: CURE H RICHARD JF ASSIER I SLIM K CLARK L PEZET D CHIPPONI J

Citation: H. Cure et al., THP ADRIAMYCIN (THP) - A PALLIATIVE TREATMENT OF LOCAL ADVANCED NON OPERABLE HEPATOCELLULAR-CARCINOMA (HCC), European journal of cancer, 31A, 1995, pp. 570-570